MRNA Rating

Crunching data... Almost there!

MRNA Intrinsic Value

Secure instant access to premium content today
Get access

MRNA Share Price History

1W 0.2%
1M 1.8%
6M (64.0%)
YTD (62.4%)
1Y (61.4%)
3Y (81.9%)
5Y 120.7%
10Y 127.2%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
$0.0$50.0$100.0$150.0Feb'24Mar'24Apr'24May'24Jun'24Jul'24Aug'24Sep'24Oct'24Nov'24Dec'24Jan'25
Value Sense

MRNA Stock Metrics

Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

MRNA Stock Financials

MRNA Income Statement Metrics

Crunching data... Almost there!

MRNA Cash Flow Statement Metrics

Crunching data... Almost there!

MRNA Income Statement Overview

Crunching data... Almost there!

MRNA Balance Sheet Overview

Crunching data... Almost there!

MRNA Stock Ratios

Crunching data... Almost there!

MRNA Earnings Surprises

Crunching data... Almost there!

MRNA Dividends

MRNA Dividend Yield

Crunching data... Almost there!

MRNA Dividend Per Share

Crunching data... Almost there!

Competing with MRNA

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
Stock picking tips. Ultimate guide 2024
Discover the secrets to successful stock picking in 2024! We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.

FAQ

What is Moderna, Inc. (MRNA) stock rating?

As of today, Moderna, Inc. has a stock rating of 6 (out of 10), which is considered Good.

is Moderna, Inc. (MRNA) a good stock to buy?

As of today, Moderna, Inc. has a Good stock rating, which is 30.3% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.